Global Human Gene Therapy Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Page: 120

Published Date: 04 Aug 2022

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Human Gene Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 and Russia-Ukraine War influence, the global Human Gene Therapy market size was valued at USD million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period.

The Human Gene Therapy market in the USA. is estimated at USD million in 2022, which currently accounts for a % share in the global market. China, the world`s second largest economy, is estimated at USD million in 2022 and holds a % percent.

Neurological Diseases occupied for % of the Human Gene Therapy global market in 2021, and it is projected to value USD million by 2028, growing at a % CAGR in next six years. In terms of product type, Non-viral Vectors segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of Human Gene Therapy include Biogen, Sarepta Therapeutics, Gilead Sciences, Amgen and Novartis, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Key Features of This Report:
This report provides in-depth analysis of the global Human Gene Therapy market, and provides market size (value, volume and average price) and CAGR for the history and forecast period (2017-2022, 2023-2028), considering 2021 as the base year
Main Human Gene Therapy manufacturers’ industry ranking, sales, revenue, price, and market share analysis. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This reports profiles key players in the global Human Gene Therapy market based on the following parameters – headquarters, production locations, products portfolio, Human Gene Therapy revenue, sales, average price and gross margin, recent developments.

Evaluation and forecast the Human Gene Therapy market size, projected growth trends, and corresponding market share analysis by type, by application, and by region. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
Highlights of the current market scenario, recent information, latest developments, and factors impacting the growth of the market
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Market Segmentation
Human Gene Therapy market is split by Type and by Application. For the period 2017-2028, the growth among segments provides accurate calculations and forecasts for sales by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type (2017-2028; USD Million)
    Non-viral Vectors
    Viral Vectors

Market segment by Application (2017-2028; USD Million)
    Neurological Diseases
    Cancer
    DMD (Duchenne Muscular Dystrophy)
    Hepatological Diseases
    Others

The key market players for global Human Gene Therapy market are listed below:
    Biogen
    Sarepta Therapeutics
    Gilead Sciences
    Amgen
    Novartis
    Orchard Therapeutics
    Spark Therapeutics
    Agc Biologics
    Anges
    Bluebird Bio
    Jazz Pharmaceuticals
    Dynavax Technologies
    Human Stem Cells Institute
    Sibiono Genetech
    Shanghai Sunway Biotech
    Uniqure N.V.
    Gensight Biologics S.A.
    Celgene Corporation
    Cellectis
    Sangamo Therapeutics
    Mustang Bio
    AGTC
    Poseida Therapeutics

Region Segment (2017-2028; USD Million)
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Gene Therapy product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Human Gene Therapy, with price, sales, revenue and global market share of Human Gene Therapy from 2019 to 2022.
Chapter 3, the Human Gene Therapy competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Gene Therapy breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Human Gene Therapy market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Human Gene Therapy.
Chapter 13, 14, and 15, to describe Human Gene Therapy sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Human Gene Therapy Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Human Gene Therapy Revenue by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Non-viral Vectors
        1.2.3 Viral Vectors
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Human Gene Therapy Revenue by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Neurological Diseases
        1.3.3 Cancer
        1.3.4 DMD (Duchenne Muscular Dystrophy)
        1.3.5 Hepatological Diseases
        1.3.6 Others
    1.4 Global Human Gene Therapy Market Size & Forecast
        1.4.1 Global Human Gene Therapy Sales in Value (2017 & 2021 & 2028)
        1.4.2 Global Human Gene Therapy Sales in Volume (2017-2028)
        1.4.3 Global Human Gene Therapy Price (2017-2028)
    1.5 Global Human Gene Therapy Production Capacity Analysis
        1.5.1 Global Human Gene Therapy Total Production Capacity (2017-2028)
        1.5.2 Global Human Gene Therapy Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Human Gene Therapy Market Drivers
        1.6.2 Human Gene Therapy Market Restraints
        1.6.3 Human Gene Therapy Trends Analysis

2 Manufacturers Profiles
    2.1 Biogen
        2.1.1 Biogen Details
        2.1.2 Biogen Major Business
        2.1.3 Biogen Human Gene Therapy Product and Services
        2.1.4 Biogen Human Gene Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.2 Sarepta Therapeutics
        2.2.1 Sarepta Therapeutics Details
        2.2.2 Sarepta Therapeutics Major Business
        2.2.3 Sarepta Therapeutics Human Gene Therapy Product and Services
        2.2.4 Sarepta Therapeutics Human Gene Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.3 Gilead Sciences
        2.3.1 Gilead Sciences Details
        2.3.2 Gilead Sciences Major Business
        2.3.3 Gilead Sciences Human Gene Therapy Product and Services
        2.3.4 Gilead Sciences Human Gene Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.4 Amgen
        2.4.1 Amgen Details
        2.4.2 Amgen Major Business
        2.4.3 Amgen Human Gene Therapy Product and Services
        2.4.4 Amgen Human Gene Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.5 Novartis
        2.5.1 Novartis Details
        2.5.2 Novartis Major Business
        2.5.3 Novartis Human Gene Therapy Product and Services
        2.5.4 Novartis Human Gene Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.6 Orchard Therapeutics
        2.6.1 Orchard Therapeutics Details
        2.6.2 Orchard Therapeutics Major Business
        2.6.3 Orchard Therapeutics Human Gene Therapy Product and Services
        2.6.4 Orchard Therapeutics Human Gene Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.7 Spark Therapeutics
        2.7.1 Spark Therapeutics Details
        2.7.2 Spark Therapeutics Major Business
        2.7.3 Spark Therapeutics Human Gene Therapy Product and Services
        2.7.4 Spark Therapeutics Human Gene Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.8 Agc Biologics
        2.8.1 Agc Biologics Details
        2.8.2 Agc Biologics Major Business
        2.8.3 Agc Biologics Human Gene Therapy Product and Services
        2.8.4 Agc Biologics Human Gene Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.9 Anges
        2.9.1 Anges Details
        2.9.2 Anges Major Business
        2.9.3 Anges Human Gene Therapy Product and Services
        2.9.4 Anges Human Gene Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.10 Bluebird Bio
        2.10.1 Bluebird Bio Details
        2.10.2 Bluebird Bio Major Business
        2.10.3 Bluebird Bio Human Gene Therapy Product and Services
        2.10.4 Bluebird Bio Human Gene Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.11 Jazz Pharmaceuticals
        2.11.1 Jazz Pharmaceuticals Details
        2.11.2 Jazz Pharmaceuticals Major Business
        2.11.3 Jazz Pharmaceuticals Human Gene Therapy Product and Services
        2.11.4 Jazz Pharmaceuticals Human Gene Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.12 Dynavax Technologies
        2.12.1 Dynavax Technologies Details
        2.12.2 Dynavax Technologies Major Business
        2.12.3 Dynavax Technologies Human Gene Therapy Product and Services
        2.12.4 Dynavax Technologies Human Gene Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.13 Human Stem Cells Institute
        2.13.1 Human Stem Cells Institute Details
        2.13.2 Human Stem Cells Institute Major Business
        2.13.3 Human Stem Cells Institute Human Gene Therapy Product and Services
        2.13.4 Human Stem Cells Institute Human Gene Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.14 Sibiono Genetech
        2.14.1 Sibiono Genetech Details
        2.14.2 Sibiono Genetech Major Business
        2.14.3 Sibiono Genetech Human Gene Therapy Product and Services
        2.14.4 Sibiono Genetech Human Gene Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.15 Shanghai Sunway Biotech
        2.15.1 Shanghai Sunway Biotech Details
        2.15.2 Shanghai Sunway Biotech Major Business
        2.15.3 Shanghai Sunway Biotech Human Gene Therapy Product and Services
        2.15.4 Shanghai Sunway Biotech Human Gene Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.16 Uniqure N.V.
        2.16.1 Uniqure N.V. Details
        2.16.2 Uniqure N.V. Major Business
        2.16.3 Uniqure N.V. Human Gene Therapy Product and Services
        2.16.4 Uniqure N.V. Human Gene Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.17 Gensight Biologics S.A.
        2.17.1 Gensight Biologics S.A. Details
        2.17.2 Gensight Biologics S.A. Major Business
        2.17.3 Gensight Biologics S.A. Human Gene Therapy Product and Services
        2.17.4 Gensight Biologics S.A. Human Gene Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.18 Celgene Corporation
        2.18.1 Celgene Corporation Details
        2.18.2 Celgene Corporation Major Business
        2.18.3 Celgene Corporation Human Gene Therapy Product and Services
        2.18.4 Celgene Corporation Human Gene Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.19 Cellectis
        2.19.1 Cellectis Details
        2.19.2 Cellectis Major Business
        2.19.3 Cellectis Human Gene Therapy Product and Services
        2.19.4 Cellectis Human Gene Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.20 Sangamo Therapeutics
        2.20.1 Sangamo Therapeutics Details
        2.20.2 Sangamo Therapeutics Major Business
        2.20.3 Sangamo Therapeutics Human Gene Therapy Product and Services
        2.20.4 Sangamo Therapeutics Human Gene Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.21 Mustang Bio
        2.21.1 Mustang Bio Details
        2.21.2 Mustang Bio Major Business
        2.21.3 Mustang Bio Human Gene Therapy Product and Services
        2.21.4 Mustang Bio Human Gene Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.22 AGTC
        2.22.1 AGTC Details
        2.22.2 AGTC Major Business
        2.22.3 AGTC Human Gene Therapy Product and Services
        2.22.4 AGTC Human Gene Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.23 Poseida Therapeutics
        2.23.1 Poseida Therapeutics Details
        2.23.2 Poseida Therapeutics Major Business
        2.23.3 Poseida Therapeutics Human Gene Therapy Product and Services
        2.23.4 Poseida Therapeutics Human Gene Therapy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

3 Human Gene Therapy Breakdown Data by Manufacturer
    3.1 Global Human Gene Therapy Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
    3.2 Global Human Gene Therapy Revenue by Manufacturer (2019, 2020, 2021, and 2022)
    3.3 Key Manufacturer Market Position in Human Gene Therapy
    3.4 Market Concentration Rate
        3.4.1 Top 3 Human Gene Therapy Manufacturer Market Share in 2021
        3.4.2 Top 6 Human Gene Therapy Manufacturer Market Share in 2021
    3.5 Global Human Gene Therapy Production Capacity by Company: 2021 VS 2022
    3.6 Manufacturer by Geography: Head Office and Human Gene Therapy Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions

4 Market Analysis by Region
    4.1 Global Human Gene Therapy Market Size by Region
        4.1.1 Global Human Gene Therapy Sales in Volume by Region (2017-2028)
        4.1.2 Global Human Gene Therapy Revenue by Region (2017-2028)
    4.2 North America Human Gene Therapy Revenue (2017-2028)
    4.3 Europe Human Gene Therapy Revenue (2017-2028)
    4.4 Asia-Pacific Human Gene Therapy Revenue (2017-2028)
    4.5 South America Human Gene Therapy Revenue (2017-2028)
    4.6 Middle East and Africa Human Gene Therapy Revenue (2017-2028)

5 Market Segment by Type
    5.1 Global Human Gene Therapy Sales in Volume by Type (2017-2028)
    5.2 Global Human Gene Therapy Revenue by Type (2017-2028)
    5.3 Global Human Gene Therapy Price by Type (2017-2028)

6 Market Segment by Application
    6.1 Global Human Gene Therapy Sales in Volume by Application (2017-2028)
    6.2 Global Human Gene Therapy Revenue by Application (2017-2028)
    6.3 Global Human Gene Therapy Price by Application (2017-2028)

7 North America by Country, by Type, and by Application
    7.1 North America Human Gene Therapy Sales by Type (2017-2028)
    7.2 North America Human Gene Therapy Sales by Application (2017-2028)
    7.3 North America Human Gene Therapy Market Size by Country
        7.3.1 North America Human Gene Therapy Sales in Volume by Country (2017-2028)
        7.3.2 North America Human Gene Therapy Revenue by Country (2017-2028)
        7.3.3 United States Market Size and Forecast (2017-2028)
        7.3.4 Canada Market Size and Forecast (2017-2028)
        7.3.5 Mexico Market Size and Forecast (2017-2028)

8 Europe by Country, by Type, and by Application
    8.1 Europe Human Gene Therapy Sales by Type (2017-2028)
    8.2 Europe Human Gene Therapy Sales by Application (2017-2028)
    8.3 Europe Human Gene Therapy Market Size by Country
        8.3.1 Europe Human Gene Therapy Sales in Volume by Country (2017-2028)
        8.3.2 Europe Human Gene Therapy Revenue by Country (2017-2028)
        8.3.3 Germany Market Size and Forecast (2017-2028)
        8.3.4 France Market Size and Forecast (2017-2028)
        8.3.5 United Kingdom Market Size and Forecast (2017-2028)
        8.3.6 Russia Market Size and Forecast (2017-2028)
        8.3.7 Italy Market Size and Forecast (2017-2028)

9 Asia-Pacific by Region, by Type, and by Application
    9.1 Asia-Pacific Human Gene Therapy Sales by Type (2017-2028)
    9.2 Asia-Pacific Human Gene Therapy Sales by Application (2017-2028)
    9.3 Asia-Pacific Human Gene Therapy Market Size by Region
        9.3.1 Asia-Pacific Human Gene Therapy Sales in Volume by Region (2017-2028)
        9.3.2 Asia-Pacific Human Gene Therapy Revenue by Region (2017-2028)
        9.3.3 China Market Size and Forecast (2017-2028)
        9.3.4 Japan Market Size and Forecast (2017-2028)
        9.3.5 Korea Market Size and Forecast (2017-2028)
        9.3.6 India Market Size and Forecast (2017-2028)
        9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
        9.3.8 Australia Market Size and Forecast (2017-2028)

10 South America by Region, by Type, and by Application
    10.1 South America Human Gene Therapy Sales by Type (2017-2028)
    10.2 South America Human Gene Therapy Sales by Application (2017-2028)
    10.3 South America Human Gene Therapy Market Size by Country
        10.3.1 South America Human Gene Therapy Sales in Volume by Country (2017-2028)
        10.3.2 South America Human Gene Therapy Revenue by Country (2017-2028)
        10.3.3 Brazil Market Size and Forecast (2017-2028)
        10.3.4 Argentina Market Size and Forecast (2017-2028)

11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Human Gene Therapy Sales by Type (2017-2028)
    11.2 Middle East & Africa Human Gene Therapy Sales by Application (2017-2028)
    11.3 Middle East & Africa Human Gene Therapy Market Size by Country
        11.3.1 Middle East & Africa Human Gene Therapy Sales in Volume by Country (2017-2028)
        11.3.2 Middle East & Africa Human Gene Therapy Revenue by Country (2017-2028)
        11.3.3 Turkey Market Size and Forecast (2017-2028)
        11.3.4 Egypt Market Size and Forecast (2017-2028)
        11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
        11.3.6 South Africa Market Size and Forecast (2017-2028)

12 Raw Material and Industry Chain
    12.1 Raw Material of Human Gene Therapy and Key Manufacturers
    12.2 Manufacturing Costs Percentage of Human Gene Therapy
    12.3 Human Gene Therapy Production Process
    12.4 Human Gene Therapy Industrial Chain

13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
    13.2 Human Gene Therapy Typical Distributors
    13.3 Human Gene Therapy Typical Customers

14 Research Findings and Conclusion

15 Appendix
    15.1 Methodology
    15.2 Research Process and Data Source
    15.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Human Gene Therapy Revenue by Type, (USD Million), 2017 & 2021 & 2028
    Table 2. Global Human Gene Therapy Revenue by Application, (USD Million), 2017 & 2021 & 2028
    Table 3. Biogen Basic Information, Manufacturing Base and Competitors
    Table 4. Biogen Major Business
    Table 5. Biogen Human Gene Therapy Product and Services
    Table 6. Biogen Human Gene Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 7. Sarepta Therapeutics Basic Information, Manufacturing Base and Competitors
    Table 8. Sarepta Therapeutics Major Business
    Table 9. Sarepta Therapeutics Human Gene Therapy Product and Services
    Table 10. Sarepta Therapeutics Human Gene Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 11. Gilead Sciences Basic Information, Manufacturing Base and Competitors
    Table 12. Gilead Sciences Major Business
    Table 13. Gilead Sciences Human Gene Therapy Product and Services
    Table 14. Gilead Sciences Human Gene Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 15. Amgen Basic Information, Manufacturing Base and Competitors
    Table 16. Amgen Major Business
    Table 17. Amgen Human Gene Therapy Product and Services
    Table 18. Amgen Human Gene Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 19. Novartis Basic Information, Manufacturing Base and Competitors
    Table 20. Novartis Major Business
    Table 21. Novartis Human Gene Therapy Product and Services
    Table 22. Novartis Human Gene Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 23. Orchard Therapeutics Basic Information, Manufacturing Base and Competitors
    Table 24. Orchard Therapeutics Major Business
    Table 25. Orchard Therapeutics Human Gene Therapy Product and Services
    Table 26. Orchard Therapeutics Human Gene Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 27. Spark Therapeutics Basic Information, Manufacturing Base and Competitors
    Table 28. Spark Therapeutics Major Business
    Table 29. Spark Therapeutics Human Gene Therapy Product and Services
    Table 30. Spark Therapeutics Human Gene Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 31. Agc Biologics Basic Information, Manufacturing Base and Competitors
    Table 32. Agc Biologics Major Business
    Table 33. Agc Biologics Human Gene Therapy Product and Services
    Table 34. Agc Biologics Human Gene Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 35. Anges Basic Information, Manufacturing Base and Competitors
    Table 36. Anges Major Business
    Table 37. Anges Human Gene Therapy Product and Services
    Table 38. Anges Human Gene Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 39. Bluebird Bio Basic Information, Manufacturing Base and Competitors
    Table 40. Bluebird Bio Major Business
    Table 41. Bluebird Bio Human Gene Therapy Product and Services
    Table 42. Bluebird Bio Human Gene Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 43. Jazz Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 44. Jazz Pharmaceuticals Major Business
    Table 45. Jazz Pharmaceuticals Human Gene Therapy Product and Services
    Table 46. Jazz Pharmaceuticals Human Gene Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 47. Dynavax Technologies Basic Information, Manufacturing Base and Competitors
    Table 48. Dynavax Technologies Major Business
    Table 49. Dynavax Technologies Human Gene Therapy Product and Services
    Table 50. Dynavax Technologies Human Gene Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 51. Human Stem Cells Institute Basic Information, Manufacturing Base and Competitors
    Table 52. Human Stem Cells Institute Major Business
    Table 53. Human Stem Cells Institute Human Gene Therapy Product and Services
    Table 54. Human Stem Cells Institute Human Gene Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 55. Sibiono Genetech Basic Information, Manufacturing Base and Competitors
    Table 56. Sibiono Genetech Major Business
    Table 57. Sibiono Genetech Human Gene Therapy Product and Services
    Table 58. Sibiono Genetech Human Gene Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 59. Shanghai Sunway Biotech Basic Information, Manufacturing Base and Competitors
    Table 60. Shanghai Sunway Biotech Major Business
    Table 61. Shanghai Sunway Biotech Human Gene Therapy Product and Services
    Table 62. Shanghai Sunway Biotech Human Gene Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 63. Uniqure N.V. Basic Information, Manufacturing Base and Competitors
    Table 64. Uniqure N.V. Major Business
    Table 65. Uniqure N.V. Human Gene Therapy Product and Services
    Table 66. Uniqure N.V. Human Gene Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 67. Gensight Biologics S.A. Basic Information, Manufacturing Base and Competitors
    Table 68. Gensight Biologics S.A. Major Business
    Table 69. Gensight Biologics S.A. Human Gene Therapy Product and Services
    Table 70. Gensight Biologics S.A. Human Gene Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 71. Celgene Corporation Basic Information, Manufacturing Base and Competitors
    Table 72. Celgene Corporation Major Business
    Table 73. Celgene Corporation Human Gene Therapy Product and Services
    Table 74. Celgene Corporation Human Gene Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 75. Cellectis Basic Information, Manufacturing Base and Competitors
    Table 76. Cellectis Major Business
    Table 77. Cellectis Human Gene Therapy Product and Services
    Table 78. Cellectis Human Gene Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 79. Sangamo Therapeutics Basic Information, Manufacturing Base and Competitors
    Table 80. Sangamo Therapeutics Major Business
    Table 81. Sangamo Therapeutics Human Gene Therapy Product and Services
    Table 82. Sangamo Therapeutics Human Gene Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 83. Mustang Bio Basic Information, Manufacturing Base and Competitors
    Table 84. Mustang Bio Major Business
    Table 85. Mustang Bio Human Gene Therapy Product and Services
    Table 86. Mustang Bio Human Gene Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 87. AGTC Basic Information, Manufacturing Base and Competitors
    Table 88. AGTC Major Business
    Table 89. AGTC Human Gene Therapy Product and Services
    Table 90. AGTC Human Gene Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 91. Poseida Therapeutics Basic Information, Manufacturing Base and Competitors
    Table 92. Poseida Therapeutics Major Business
    Table 93. Poseida Therapeutics Human Gene Therapy Product and Services
    Table 94. Poseida Therapeutics Human Gene Therapy Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 95. Global Human Gene Therapy Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
    Table 96. Global Human Gene Therapy Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
    Table 97. Market Position of Manufacturers in Human Gene Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
    Table 98. Global Human Gene Therapy Production Capacity by Company, (K Units): 2020 VS 2021
    Table 99. Head Office and Human Gene Therapy Production Site of Key Manufacturer
    Table 100. Human Gene Therapy New Entrant and Capacity Expansion Plans
    Table 101. Human Gene Therapy Mergers & Acquisitions in the Past Five Years
    Table 102. Global Human Gene Therapy Sales by Region (2017-2022) & (K Units)
    Table 103. Global Human Gene Therapy Sales by Region (2023-2028) & (K Units)
    Table 104. Global Human Gene Therapy Revenue by Region (2017-2022) & (USD Million)
    Table 105. Global Human Gene Therapy Revenue by Region (2023-2028) & (USD Million)
    Table 106. Global Human Gene Therapy Sales by Type (2017-2022) & (K Units)
    Table 107. Global Human Gene Therapy Sales by Type (2023-2028) & (K Units)
    Table 108. Global Human Gene Therapy Revenue by Type (2017-2022) & (USD Million)
    Table 109. Global Human Gene Therapy Revenue by Type (2023-2028) & (USD Million)
    Table 110. Global Human Gene Therapy Price by Type (2017-2022) & (US$/Unit)
    Table 111. Global Human Gene Therapy Price by Type (2023-2028) & (US$/Unit)
    Table 112. Global Human Gene Therapy Sales by Application (2017-2022) & (K Units)
    Table 113. Global Human Gene Therapy Sales by Application (2023-2028) & (K Units)
    Table 114. Global Human Gene Therapy Revenue by Application (2017-2022) & (USD Million)
    Table 115. Global Human Gene Therapy Revenue by Application (2023-2028) & (USD Million)
    Table 116. Global Human Gene Therapy Price by Application (2017-2022) & (US$/Unit)
    Table 117. Global Human Gene Therapy Price by Application (2023-2028) & (US$/Unit)
    Table 118. North America Human Gene Therapy Sales by Country (2017-2022) & (K Units)
    Table 119. North America Human Gene Therapy Sales by Country (2023-2028) & (K Units)
    Table 120. North America Human Gene Therapy Revenue by Country (2017-2022) & (USD Million)
    Table 121. North America Human Gene Therapy Revenue by Country (2023-2028) & (USD Million)
    Table 122. North America Human Gene Therapy Sales by Type (2017-2022) & (K Units)
    Table 123. North America Human Gene Therapy Sales by Type (2023-2028) & (K Units)
    Table 124. North America Human Gene Therapy Sales by Application (2017-2022) & (K Units)
    Table 125. North America Human Gene Therapy Sales by Application (2023-2028) & (K Units)
    Table 126. Europe Human Gene Therapy Sales by Country (2017-2022) & (K Units)
    Table 127. Europe Human Gene Therapy Sales by Country (2023-2028) & (K Units)
    Table 128. Europe Human Gene Therapy Revenue by Country (2017-2022) & (USD Million)
    Table 129. Europe Human Gene Therapy Revenue by Country (2023-2028) & (USD Million)
    Table 130. Europe Human Gene Therapy Sales by Type (2017-2022) & (K Units)
    Table 131. Europe Human Gene Therapy Sales by Type (2023-2028) & (K Units)
    Table 132. Europe Human Gene Therapy Sales by Application (2017-2022) & (K Units)
    Table 133. Europe Human Gene Therapy Sales by Application (2023-2028) & (K Units)
    Table 134. Asia-Pacific Human Gene Therapy Sales by Region (2017-2022) & (K Units)
    Table 135. Asia-Pacific Human Gene Therapy Sales by Region (2023-2028) & (K Units)
    Table 136. Asia-Pacific Human Gene Therapy Revenue by Region (2017-2022) & (USD Million)
    Table 137. Asia-Pacific Human Gene Therapy Revenue by Region (2023-2028) & (USD Million)
    Table 138. Asia-Pacific Human Gene Therapy Sales by Type (2017-2022) & (K Units)
    Table 139. Asia-Pacific Human Gene Therapy Sales by Type (2023-2028) & (K Units)
    Table 140. Asia-Pacific Human Gene Therapy Sales by Application (2017-2022) & (K Units)
    Table 141. Asia-Pacific Human Gene Therapy Sales by Application (2023-2028) & (K Units)
    Table 142. South America Human Gene Therapy Sales by Country (2017-2022) & (K Units)
    Table 143. South America Human Gene Therapy Sales by Country (2023-2028) & (K Units)
    Table 144. South America Human Gene Therapy Revenue by Country (2017-2022) & (USD Million)
    Table 145. South America Human Gene Therapy Revenue by Country (2023-2028) & (USD Million)
    Table 146. South America Human Gene Therapy Sales by Type (2017-2022) & (K Units)
    Table 147. South America Human Gene Therapy Sales by Type (2023-2028) & (K Units)
    Table 148. South America Human Gene Therapy Sales by Application (2017-2022) & (K Units)
    Table 149. South America Human Gene Therapy Sales by Application (2023-2028) & (K Units)
    Table 150. Middle East & Africa Human Gene Therapy Sales by Region (2017-2022) & (K Units)
    Table 151. Middle East & Africa Human Gene Therapy Sales by Region (2023-2028) & (K Units)
    Table 152. Middle East & Africa Human Gene Therapy Revenue by Region (2017-2022) & (USD Million)
    Table 153. Middle East & Africa Human Gene Therapy Revenue by Region (2023-2028) & (USD Million)
    Table 154. Middle East & Africa Human Gene Therapy Sales by Type (2017-2022) & (K Units)
    Table 155. Middle East & Africa Human Gene Therapy Sales by Type (2023-2028) & (K Units)
    Table 156. Middle East & Africa Human Gene Therapy Sales by Application (2017-2022) & (K Units)
    Table 157. Middle East & Africa Human Gene Therapy Sales by Application (2023-2028) & (K Units)
    Table 158. Human Gene Therapy Raw Material
    Table 159. Key Manufacturers of Human Gene Therapy Raw Materials
    Table 160. Direct Channel Pros & Cons
    Table 161. Indirect Channel Pros & Cons
    Table 162. Human Gene Therapy Typical Distributors
    Table 163. Human Gene Therapy Typical Customers
List of Figures
    Figure 1. Human Gene Therapy Picture
    Figure 2. Global Human Gene Therapy Revenue Market Share by Type in 2021
    Figure 3. Non-viral Vectors
    Figure 4. Viral Vectors
    Figure 5. Global Human Gene Therapy Revenue Market Share by Application in 2021
    Figure 6. Neurological Diseases
    Figure 7. Cancer
    Figure 8. DMD (Duchenne Muscular Dystrophy)
    Figure 9. Hepatological Diseases
    Figure 10. Others
    Figure 11. Global Human Gene Therapy Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
    Figure 12. Global Human Gene Therapy Revenue and Forecast (2017-2028) & (USD Million)
    Figure 13. Global Human Gene Therapy Sales (2017-2028) & (K Units)
    Figure 14. Global Human Gene Therapy Price (2017-2028) & (US$/Unit)
    Figure 15. Global Human Gene Therapy Production Capacity (2017-2028) & (K Units)
    Figure 16. Global Human Gene Therapy Production Capacity by Geographic Region: 2022 VS 2028
    Figure 17. Human Gene Therapy Market Drivers
    Figure 18. Human Gene Therapy Market Restraints
    Figure 19. Human Gene Therapy Market Trends
    Figure 20. Global Human Gene Therapy Sales Market Share by Manufacturer in 2021
    Figure 21. Global Human Gene Therapy Revenue Market Share by Manufacturer in 2021
    Figure 22. Human Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
    Figure 23. Top 3 Human Gene Therapy Manufacturer (Revenue) Market Share in 2021
    Figure 24. Top 6 Human Gene Therapy Manufacturer (Revenue) Market Share in 2021
    Figure 25. Global Human Gene Therapy Sales Market Share by Region (2017-2028)
    Figure 26. Global Human Gene Therapy Revenue Market Share by Region (2017-2028)
    Figure 27. North America Human Gene Therapy Revenue (2017-2028) & (USD Million)
    Figure 28. Europe Human Gene Therapy Revenue (2017-2028) & (USD Million)
    Figure 29. Asia-Pacific Human Gene Therapy Revenue (2017-2028) & (USD Million)
    Figure 30. South America Human Gene Therapy Revenue (2017-2028) & (USD Million)
    Figure 31. Middle East & Africa Human Gene Therapy Revenue (2017-2028) & (USD Million)
    Figure 32. Global Human Gene Therapy Sales Market Share by Type (2017-2028)
    Figure 33. Global Human Gene Therapy Revenue Market Share by Type (2017-2028)
    Figure 34. Global Human Gene Therapy Price by Type (2017-2028) & (US$/Unit)
    Figure 35. Global Human Gene Therapy Sales Market Share by Application (2017-2028)
    Figure 36. Global Human Gene Therapy Revenue Market Share by Application (2017-2028)
    Figure 37. Global Human Gene Therapy Price by Application (2017-2028) & (US$/Unit)
    Figure 38. North America Human Gene Therapy Sales Market Share by Type (2017-2028)
    Figure 39. North America Human Gene Therapy Sales Market Share by Application (2017-2028)
    Figure 40. North America Human Gene Therapy Sales Market Share by Country (2017-2028)
    Figure 41. North America Human Gene Therapy Revenue Market Share by Country (2017-2028)
    Figure 42. United States Human Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 43. Canada Human Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 44. Mexico Human Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 45. Europe Human Gene Therapy Sales Market Share by Type (2017-2028)
    Figure 46. Europe Human Gene Therapy Sales Market Share by Application (2017-2028)
    Figure 47. Europe Human Gene Therapy Sales Market Share by Country (2017-2028)
    Figure 48. Europe Human Gene Therapy Revenue Market Share by Country (2017-2028)
    Figure 49. Germany Human Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 50. France Human Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 51. United Kingdom Human Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 52. Russia Human Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 53. Italy Human Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 54. Asia-Pacific Human Gene Therapy Sales Market Share by Region (2017-2028)
    Figure 55. Asia-Pacific Human Gene Therapy Sales Market Share by Application (2017-2028)
    Figure 56. Asia-Pacific Human Gene Therapy Sales Market Share by Region (2017-2028)
    Figure 57. Asia-Pacific Human Gene Therapy Revenue Market Share by Region (2017-2028)
    Figure 58. China Human Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 59. Japan Human Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 60. Korea Human Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 61. India Human Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 62. Southeast Asia Human Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 63. Australia Human Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 64. South America Human Gene Therapy Sales Market Share by Type (2017-2028)
    Figure 65. South America Human Gene Therapy Sales Market Share by Application (2017-2028)
    Figure 66. South America Human Gene Therapy Sales Market Share by Country (2017-2028)
    Figure 67. South America Human Gene Therapy Revenue Market Share by Country (2017-2028)
    Figure 68. Brazil Human Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 69. Argentina Human Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 70. Middle East & Africa Human Gene Therapy Sales Market Share by Type (2017-2028)
    Figure 71. Middle East & Africa Human Gene Therapy Sales Market Share by Application (2017-2028)
    Figure 72. Middle East & Africa Human Gene Therapy Sales Market Share by Region (2017-2028)
    Figure 73. Middle East & Africa Human Gene Therapy Revenue Market Share by Region (2017-2028)
    Figure 74. Turkey Human Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 75. Egypt Human Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 76. Saudi Arabia Human Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 77. South Africa Human Gene Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 78. Manufacturing Cost Structure Analysis of Human Gene Therapy in 2021
    Figure 79. Manufacturing Process Analysis of Human Gene Therapy
    Figure 80. Human Gene Therapy Industrial Chain
    Figure 81. Sales Channel: Direct Channel vs Indirect Channel
    Figure 82. Methodology
    Figure 83. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Biogen
Sarepta Therapeutics
Gilead Sciences
Amgen
Novartis
Orchard Therapeutics
Spark Therapeutics
Agc Biologics
Anges
Bluebird Bio
Jazz Pharmaceuticals
Dynavax Technologies
Human Stem Cells Institute
Sibiono Genetech
Shanghai Sunway Biotech
Uniqure N.V.
Gensight Biologics S.A.
Celgene Corporation
Cellectis
Sangamo Therapeutics
Mustang Bio
AGTC
Poseida Therapeutics

Related Reports

Global Human Gene Therapy Supply, Demand and Key Producers, 2023-2029

Global Human Gene Therapy Supply, Demand and Key Producers, 2023-2029

date 06 Sep 2023

date Pharma & Healthcare

The global Human Gene Therapy market size is expected to reach $ 7778.9 million by 2029, rising at a market growth of 6.0% CAGR during the forecast period (2023-2029).

Global Human Gene Therapy Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Human Gene Therapy Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 06 Sep 2023

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Human Gene Therapy market size was valued at USD 5163.5 million in 2022 and is forecast to a readjusted size of USD 7778.9 million by 2029 with a CAGR of 6.0% during review period.

Global Human Gene Therapy Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Human Gene Therapy Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 14 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Human Gene Therapy market size was valued at USD 5163.5 million in 2023 and is forecast to a readjusted size of USD 7778.9 million by 2030 with a CAGR of 6.0% during review period.

Product Tags

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>